Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 3
2004 2
2005 6
2006 8
2007 7
2008 2
2009 7
2010 9
2011 10
2012 9
2013 27
2014 22
2015 15
2016 26
2017 27
2018 26
2019 29
2020 30
Text availability
Article attribute
Article type
Publication date

Search Results

234 results
Results by year
Filters applied: . Clear all
Page 1
Did you mean hong ming liu (31 results)?
Lysine demethylase 5B (KDM5B): A potential anti-cancer drug target.
Zheng YC, Chang J, Wang LC, Ren HM, Pang JR, Liu HM. Zheng YC, et al. Among authors: liu hm. Eur J Med Chem. 2019 Jan 1;161:131-140. doi: 10.1016/j.ejmech.2018.10.040. Epub 2018 Oct 17. Eur J Med Chem. 2019. PMID: 30343192 Review.
Potent 5-Cyano-6-phenyl-pyrimidin-Based Derivatives Targeting DCN1-UBE2M Interaction.
Zhou W, Ma L, Ding L, Guo Q, He Z, Yang J, Qiao H, Li L, Yang J, Yu S, Zhao L, Wang S, Liu HM, Suo Z, Zhao W. Zhou W, et al. Among authors: liu hm. J Med Chem. 2019 Jun 13;62(11):5382-5403. doi: 10.1021/acs.jmedchem.9b00003. Epub 2019 Jun 3. J Med Chem. 2019. PMID: 31157974
Epigenetic Modification in Macrophages: A Promising Target for Tumor and Inflammation-associated Disease Therapy.
Sun P, Zhang SJ, Maksim S, Yao YF, Liu HM, Du J. Sun P, et al. Among authors: liu hm. Curr Top Med Chem. 2019;19(15):1350-1362. doi: 10.2174/1568026619666190619143706. Curr Top Med Chem. 2019. PMID: 31215380 Review.
Derivative of 5-cyano-6-phenylpyrimidin antagonizes ABCB1- and ABCG2-mediated multidrug resistance.
Wang JQ, Wang B, Lei ZN, Teng QX, Li JY, Zhang W, Ji N, Cai CY, Ma LY, Liu HM, Chen ZS. Wang JQ, et al. Among authors: liu hm. Eur J Pharmacol. 2019 Nov 15;863:172611. doi: 10.1016/j.ejphar.2019.172611. Epub 2019 Aug 30. Eur J Pharmacol. 2019. PMID: 31476282
Expression of programmed death ligand 1 (PD-L1) is associated with metastasis and differentiation in gastric cancer.
He PX, Ma ZL, Han H, Zhang XY, Niu SH, Du LN, Zheng YC, Liu HM. He PX, et al. Among authors: liu hm. Life Sci. 2020 Feb 1;242:117247. doi: 10.1016/j.lfs.2019.117247. Epub 2019 Dec 31. Life Sci. 2020. PMID: 31899223
IL33 attenuates ventricular remodeling after myocardial infarction through inducing alternatively activated macrophages ethical standards statement.
Li J, Shen D, Tang J, Wang Y, Wang B, Xiao Y, Cao C, Shi X, Liu HM, Zhao W, Zhang J. Li J, et al. Among authors: liu hm. Eur J Pharmacol. 2019 Jul 5;854:307-319. doi: 10.1016/j.ejphar.2019.04.046. Epub 2019 Apr 27. Eur J Pharmacol. 2019. PMID: 31039343
Targeting the DCN1-UBC12 protein-protein interaction: novel approaches and future directions.
Fang Y, Yu B, Liao G, Liu HM. Fang Y, et al. Among authors: liu hm. Future Med Chem. 2019 Nov;11(22):2869-2871. doi: 10.4155/fmc-2019-0253. Epub 2019 Oct 31. Future Med Chem. 2019. PMID: 31668094 Free article. No abstract available.
Potent hydrazone derivatives targeting esophageal cancer cells.
Li LY, Peng JD, Zhou W, Qiao H, Deng X, Li ZH, Li JD, Fu YD, Li S, Sun K, Liu HM, Zhao W. Li LY, et al. Among authors: liu hm. Eur J Med Chem. 2018 Mar 25;148:359-371. doi: 10.1016/j.ejmech.2018.02.033. Epub 2018 Feb 14. Eur J Med Chem. 2018. PMID: 29475156
Baicalin, a natural LSD1 inhibitor.
Zheng YC, Shen DD, Ren M, Liu XQ, Wang ZR, Liu Y, Zhang QN, Zhao LJ, Zhao LJ, Ma JL, Yu B, Liu HM. Zheng YC, et al. Among authors: liu hm. Bioorg Chem. 2016 Dec;69:129-131. doi: 10.1016/j.bioorg.2016.10.004. Epub 2016 Oct 11. Bioorg Chem. 2016. PMID: 27814566
Catalytic asymmetric synthesis of biologically important 3-hydroxyoxindoles: an update.
Yu B, Xing H, Yu DQ, Liu HM. Yu B, et al. Among authors: liu hm. Beilstein J Org Chem. 2016 May 18;12:1000-1039. doi: 10.3762/bjoc.12.98. eCollection 2016. Beilstein J Org Chem. 2016. PMID: 27340490 Free PMC article. Review.
234 results
Jump to page